Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
A critical step in cancer growth and metastasis is the dissolution of the extracellular matrix surrounding the malignant tumor, which leads to tumor cell invasion and dissemination. Type I collagen degradation involves the initial action of collagenolytic matrix metalloproteinases (MMP-1, -8, and -13) activated by MMP-3 (stromelysin-1). The role of interactive matrix serine proteinases (MSPs), including tumor-associated trypsinogens, has been unclear in collagenolysis. Now, we provide evidence that the major isoenzyme of human tumor-associated trypsinogens, trypsin-2, can directly activate three collagenolytic proMMPs as well as proMMP-3. These proMMP activations are inhibited by tumor-associated trypsin inhibitor (TATI). Furthermore, we demonstrate that trypsin-2 efficiently degrades native soluble type I collagen, which can be inhibited by TATI. However, cell culture studies showed that trypsin-2 transfection into the HSC-3 cell line did not result in MMP-1, -3, -8, and -13 activation but affected MMP-3 and -8 production at the protein level. These findings indicate that human trypsin-2 can be regarded as a potent tumor-associated matrix serine protease capable of being the initial activator of the collagenolytic MMP activation network as well as directly attacking type I collagen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The former encodes trypsin 2, involved in type I and II collagen degradation 27,28”
From Sex-specific gene expression signatures of calcific aortic valve stenosis in a large collection of human tissues (2026) · cites this paper as [27]
Citations
Cites
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Matrix Metalloproteinase-2 Is an Interstitial Collagenase
Aimes, R. T., & Quigley, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5872 · Cited by 944
Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938
Matrix Metalloproteinase-8 Is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells
Hanemaaijer, R., Sorsa, T., Konttinen, Y. T., Ding, Y., Sutinen, M., Visser, H., van Hinsbergh, V. W. M., Helaakoski, T., Kainulainen, T., Rönkä, H., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31504 · Cited by 489
Self-citationStromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
Murphy, G., Cockett, M. I., Stephens, P. E., Smith, B. J., & Docherty, A. J. P. (1987) · Biochemical Journal · doi:10.1042/bj2480265 · Cited by 464
Kähäri, V.-M., & Saarialho-Kere, U. (1999) · Annals of Medicine · doi:10.3109/07853899909019260 · Cited by 408
Shamamian, P., Schwartz, J. D., Pocock, B. J. Z., Monea, S., Whiting, D., Marcus, S. G., & Mignatti, P. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10014 · Cited by 353
Airola, K., Karonen, T., Vaalamo, M., Lehti, K., Lohi, J., Kariniemi, A.-L., Keski-Oja, J., & Saarialho-Kere, U. K. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690417 · Cited by 227
Research works printed but not linked: 37
- Roberts R., 1995, Crit. Rev. Eukaryotic Gen. Expr., 5
- Birkedal-Hansen H., 1995, Curr. Opin. Cell. Biol. 7, 728−735
- Springman E. B., 1990, 87, 364−368
- Van Wart H. E., 1990, Proc. Natl. Acad. Sci. U.S.A. 87, 5578−5582
- Neurath H., 1984, Science 224, 350−357
- Sheele G., 1981, Gastroenterology 80, 461−473
- Wiegand U., 1993, Gene 136, 167−175
- Stenman U. H., 1988, Biol. Chem. Hoppe-Seyler, 369, 14
- Koivunen E., 1990, Cancer Res. 50, 2375−2378
- Kato Y., 1998, Eur. J. Cancer, 34
- Miyata S., 1998, Clin. Exp. Metastasis 16, 613−622
- Stenman U. H., 1990, Scand. J. Clin. Lab. Invest. Suppl., 201, 101
- Thomas G. T., 1999, Oral Oncol. 35, 227−233
- Suzuki K., 1990, Biochemistry 29, 10261−10270
- Sang Q. X., 1995, Biochim. Biophys. Acta, 1251, 108
- Wilhelm S. M., 1987, Proc. Natl. Acad. Sci. U.S.A. 84, 6725−6727
- Knäuper V., 1996, J. Biol. Chem., 271
- Lindy O., 1997, Arthritis Rheum. 40, 1391−1399
- Sorsa T., 1994, Ann. N.Y. Acad. Sci. 6, 112−131
- Boyum A., 1968, Scand. J. Clin. Lab. Invest. Suppl., 97, 89
- Hibbs M. S., 1984, Coll. Relat. Res. 4, 467−477
- Konttinen Y. T., 1998, Matrix Biol. 17, 585−601
- Baumann M., 1990, Anal. Biochem. 190, 198−208
- Bergmann U., 1989, J. Clin. Chem. Clin. Biochem., 27
- Itkonen O., 1990, J. Lab. Clin. Med., 115
- Koivunen E., 1991, Cancer Res. 51, 2107−2112
- Craik C. S., 1985, Science 228, 291−297
- Nagase H., 1990, Biochemistry 29, 5783−5789
- Tschesche H., 1992, Matrix Suppl. 1, 245−255
- Weiss S. J., 1989, N. Engl. J. Med., 320
- Cole A. A., 1996, J. Biol. Chem., 271
- Prikk K., 2001, 33, 437−444
- Kim M. H., 2001, Anticancer Res., 21, 50
- Bachmeier B. E., 2000, Biol. Chem. 381, 509−516
- Herman M. P., 2001, Circulation 104
- Kafienah W., 1998, Biochem. J., 220
- Abbreviations MMP, matrix metalloproteinase
Cited by
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
“The 51-kDa latent proenzyme can be activated by proteolytic removal of the prodomain by, for instance, the serine proteases trypsin-2 (Moilanen et al. 2003) and matriptase (Jin et al. 2006), yielding a 43-kDa active enzyme in humans.”
BackgroundSorsa, T., Tjäderhane, L., Konttinen, Y. T., Lauhio, A., Salo, T., Lee, H., Golub, L. M., Brown, D. L., & Mäntylä, P. (2006) · Annals of Medicine · doi:10.1080/07853890600800103 · Cited by 673
“Furthermore, human trypsin-2 can also directly degrade native interstitial type I and II collagens (71,72).”
BackgroundSelf-citationGelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Matrix metalloproteinases (MMPs) in oral diseases
Sorsa, T., Tjäderhane, L., & Salo, T. (2004) · Oral Diseases · doi:10.1111/j.1601-0825.2004.01038.x · Cited by 618
Self-citationTranscriptomic dissection of tongue squamous cell carcinoma
Ye, H., Yu, T., Temam, S., Ziober, B. L., Wang, J., Schwartz, J. L., Mao, L., Wong, D. T., & Zhou, X. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-69 · Cited by 344
“MMPs are a large family of proteinases which remodel extracellular matrix (ECM) components and play a significant role in tumor development, survival, invasion and metastasis [11-13].”
BackgroundDesigning bioresponsive nanomaterials for intracellular self-assembly
Chagri, S., Ng, D. Y. W., & Weil, T. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00373-x · Cited by 261
Sbardella, D., Fasciglione, G. F., Gioia, M., Ciaccio, C., Tundo, G. R., Marini, S., & Coletta, M. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.015 · Cited by 247
“At the protein level, Moldovan and coworkers found that the MMP-13 protein was preferentially localized in the lower intermediary and deep layers (deep zone) of human OA cartilage (Moldovan et al., 1997), while Tetlow and colleagues associated the presence of MMP-13 at the superficial cartilage zone characterized by f…”
BackgroundMatrix Metalloproteinases in Atherothrombosis
Bäck, M., Ketelhuth, D. F. J., & Agewall, S. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.002 · Cited by 195
“In addition to activation by other MMPs, pro-MMP-3 can also be activated by trypsin.(207) TIMP-3 is an insoluble ECM-binding protein that mainly inhibits pro-MMP-3 activation.”
BackgroundMatrix metalloproteases and PAR1 activation
Austin, K. M., Covic, L., & Kuliopulos, A. (2013) · Blood · doi:10.1182/blood-2012-09-355958 · Cited by 192
Montel, V., Kleeman, J., Agarwal, D., Spinella, D., Kawai, K., & Tarin, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2047 · Cited by 169
“Importantly, MMP-8, like other MMP enzymes, is secreted as a proenzyme, which can subsequently be activated by a number of other enzymes including MMP-3 (37) and serine proteases, which themselves can be inactivated by specific tissue inhibitors (38).”
BackgroundSoreide, K., Janssen, E., Körner, H., & Baak, J. (2006) · The Journal of Pathology · doi:10.1002/path.1999 · Cited by 158
“Although TATI is highly co-expressed in CRC, experimental inhibition of trypsin with TATI is only partially successful [35], and TATI is not a useful tumour marker compared with carcino-embryonic antigen [53].”
BackgroundHepatitis C Virus-Replicating Hepatocytes Induce Fibrogenic Activation of Hepatic Stellate Cells
Schulze-Krebs, A., Preimel, D., Popov, Y. V., Bartenschlager, R. F. W., Lohmann, V., Pinzani, M., & Schuppan, D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.089 · Cited by 162
Collagenolytic Proteinases in Keratoconus
Mackiewicz, Z., Määttã, M., Stenman, M., Konttinen, L., Tervo, T. T., & Konttinen, Y. T. (2006) · Cornea · doi:10.1097/01.ico.0000208820.32614.00 · Cited by 130
Self-citationCollagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer
Korpi, J. T., Kervinen, V., Maklin, H., Väänänen, A., Lahtinen, M., Läärä, E., Ristimaki, A. P., Thomas, G. J., Ylipalosaari, M., Åström, P., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604239 · Cited by 130
“HSC-3 tongue carcinoma cells were grown as previously described (Moilanen et al, 2003).”
MethodSelf-citationThe Role of MMP8 in Cancer: A Systematic Review
Juurikka, K., Butler, G. S., Salo, T. A., Nyberg, P., & Åström, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184506 · Cited by 128
Self-citationRadisky, E. S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107347 · Cited by 144
“Trypsins , another branch of the S1 family, are also implicated in ECM degradation during tumor cell invasion (71), activation of uPA (72) and MMP zymogens (73, 74), and signaling through cleavage of PARs (75, 76).”
BackgroundQian, J., Niu, J., Li, M., Chiao, P. J., & Tsao, M.-S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3208 · Cited by 115
Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma
Ziober, A. F., Patel, K. R., Alawi, F., Gimotty, P. A., Weber, R. S., Feldman, M. M., Chalian, A. A., Weinstein, G. S., Hunt, J. L., & Ziober, B. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0535 · Cited by 122
Ríos, M. H., Sorsa, T. A., Obregón, F., Tervahartiala, T. I., Valenzuela, M. A., Pozo, P., Dutzan, N., Lesaffre, E. M. E. H., Molas, M., & Gamonal, J. A. (2009) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2009.01488.x · Cited by 108
“ProMMP-13 in turn can also be initially activated by serine proteases (Sorsa et al. 1992, Moilanen et al. 2003), and with respect to periodontal inflammation, proteases from potent periodontopathogens can/may also activate proMMPs (Sorsa et al. 1992).”
Self-citationTrypsins and their role in carcinoma growth
Nyberg, P., Ylipalosaari, M., Sorsa, T. A., & Salo, T. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.024 · Cited by 100
Self-citationWit, M. D., Keil, D., van der Ven, K., Vandamme, S., Witters, E., & Coen, W. D. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.03.003 · Cited by 106
“MMPs are a family of endopeptidases that degrade proteins of the ECM, such as collagen, and are involved in several processes critical for normal zebrafish development (Coyle et al., 2008).”
BackgroundTen years in the life of an enzyme: the story of the human MMP-13 (collagenase-3)
Tardif, G., Reboul, P., Pelletier, J., & Martel‐Pelletier, J. (2004) · Modern Rheumatology · doi:10.1007/s10165-004-0292-7 · Cited by 87
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Li, S., Pritchard, D. M., & Yu, L.-G. (2022) · Cancers · doi:10.3390/cancers14133263 · Cited by 82
“MMP-13 can also be activated by MMP-3 [27] and the major isoenzyme of human tumour-associated trypsinogen, trypsin-2 [48].”
BackgroundBiochemistry and Clinical Role of Trypsinogens and Pancreatic Secretory Trypsin Inhibitor
Paju, A., & Stenman, U. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523852 · Cited by 76
Self-citationPan, H., Yamada, H., Chida, J., Wang, S., Yano, M., Yao, M., Zhu, J., & Kido, H. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq358 · Cited by 72
Emerging roles of serine proteinases in tissue turnover in arthritis
Milner, J. M., Patel, A., & Rowan, A. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24046 · Cited by 68
Matrix Metalloproteinase Dependent and Independent Collagen Degradation
Song, F., Wisithphrom, K., Zhou, J., & Windsor, L. J. (2006) · Frontiers in bioscience · doi:10.2741/2036 · Cited by 77
Park, K. C., Dharmasivam, M., & Richardson, D. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186805 · Cited by 73
“In fact, TAT-2 activates proMMPs to begin protease cascades and was demonstrated to activate multiple pro-MMPs [63,66].”
BackgroundGaber, A., Johansson, M., Stenman, U., Hotakainen, K., Pontén, F., Glimelius, B. L. G., Bjartell, A. S., Jirström, K., & Birgisson, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605047 · Cited by 67
“It is expressed by many tumours and also plays a significant role in tumour invasion (Koivunen et al, 1991; Moilanen et al, 2003; Paju et al, 2004).”
BackgroundSelf-citationExpression of Trypsinogen-1, Trypsinogen-2, and Tumor-Associated Trypsin Inhibitor in Ovarian Cancer
Paju, A., Vartiainen, J., Haglund, C., Itkonen, O., von Boguslawski, K., Leminen, A., Wahlström, T., & Stenman, U. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0204-03 · Cited by 60
“Because trypsin is thought to mediate tumor invasion (12, 16) and TATI is a trypsin inhibitor, the correlation between high TATI concentrations in serum and tissue and poor prognosis may seem surprising.”
BackgroundSelf-citationYamamoto, N., Kawaguchi, K., Fujihara, H., Hasebe, M., Kishi, Y., Yasukawa, M., Kumagai, K., & Hamada, Y. (2017) · International Journal of Oral Science · doi:10.1038/ijos.2017.37 · Cited by 59
Kordes, C., Brookmann, S., H??ussinger, D., & Klonowski-Stumpe, H. (2005) · Pancreas · doi:10.1097/01.mpa.0000168222.05591.a0 · Cited by 52
“Secreted MMP-3 is most likely involved in this process, because MMP-13 is activated by proteolytic activity of MMP-3.(39) TGF-b1 increased the mRNA amount of procollagen a2(I), TIMP-1, and a-SMA as well as enhanced protein synthesis of collagen type I and a-SMA, although the expression FIGURE 9.”
BackgroundInfluentialLauhio, A., Sorsa, T. A., Srinivas, R., Stenman, M., Tervahartiala, T. I., Stenman, U., Grönhagen‐Riska, C., & Honkanen, E. O. (2008) · Annals of Medicine · doi:10.1080/07853890801923746 · Cited by 46
“It is noteworthy that TRY-2 is a very efficient activator of proMMPcascades such as proMMP-8 and -9 in vitro (6,9).”
BackgroundSelf-citationDigging in the “Soil” of the Aorta to Understand the Growth of Abdominal Aortic Aneurysms
Curci, J. A. (2009) · Vascular · doi:10.2310/6670.2008.00085 · Cited by 46
Stenman, M., Ainola, M., Valmu, L., Bjartell, A., Ma, G., Stenman, U.-H., Sorsa, T., Luukkainen, R., & Konttinen, Y. T. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61200-x · Cited by 37
“Recent studies have furthermore shown that TRY-2 activates collagenases (MMP-1, -8, -13) and was tentatively shown to degrade type I collagen.(12) We therefore decided to assess if TRY-2 is active against the main structural matrix protein of hyaline articular cartilage, type II collagen.”
BackgroundSelf-citationGene Set Signature of Reversal Reaction Type I in Leprosy Patients
Orlova, M., Cobat, A., Hương, N. T., Ba, N. N., Thuc, N. V., Spencer, J. S., Nédélec, Y., Barreiro, L. B., Thai, V. H., Abel, L., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003624 · Cited by 36
Hayashi, K., Hosoe, M., Kizaki, K., Fujii, S., Kanahara, H., Takahashi, T., & Sakumoto, R. (2017) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-017-0237-6 · Cited by 36
“PRSS2 is a member of the trypsin family of serine proteases and degrades type I collagen directly or indirectly by activating several procollagenolytic matrix metalloproteinases (MMPs) [52, 53].”
BackgroundMatrilysins and Stromelysins in Pathogenesis and Diagnostics of Cancers
Piskór, B. M., Przylipiak, A., Dąbrowska, E., Niczyporuk, M., & Ławicki, S. (2020) · Cancer Management and Research · doi:10.2147/cmar.s235776 · Cited by 40
“MMP-3 is secreted as inactive proenzyme (51-kDa) form which is activated in the extracellular space by proteases, notably plasmin,(53) and also can be activated by proteolytic removal of the prodomain by the serine proteases trypsin-2 and matriptase, to active form (43-kDa).(2,55,56) Active form of MMP-3 can hydrolyze…”
Backgroundİlgenli, T., Vardar‐Şengül, S., Gürkan, A., Sorsa, T. A., Stackelberg, S., Köse, T., & Atilla, G. (2006) · Oral Diseases · doi:10.1111/j.1601-0825.2006.01244.x · Cited by 34
Self-citationTsai, C., Chou, Y., & Fu, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.10.011 · Cited by 34
Lauer‐Fields, J. L., Kele, P., Sui, G., Nagase, H., Leblanc, R. M., & Fields, G. B. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00460-3 · Cited by 33
Expression of tumor‐associated trypsinogens (TAT‐1 and TAT‐2) in prostate cancer
Bjartell, A. S., Paju, A., Zhang, W., Gadaleanu, V., Hansson, J., Landberg, G., & Stenman, U. (2005) · The Prostate · doi:10.1002/pros.20236 · Cited by 31
“Furthermore, we have recently shown that trypsin also activates procollagenases (MMP-1, -8, and -13) and is capable of directly degrading type I collagen [39].”
BackgroundSelf-citationHuang, G., Hu, Z., Li, M., Cui, Y., Li, Y., Guo, L., Jiang, W. B., & Lu, S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm140 · Cited by 31
Proteomics: Is It an Approach To Understand the Progression of Chronic Lung Disorders?
Sepper, R., & Prikk, K. (2004) · Journal of Proteome Research · doi:10.1021/pr049955x · Cited by 31
Iwaki, K., Shibata, K., Ohta, M., Endo, Y., Uchida, H., Tominaga, M., Okunaga, R., Kai, S., & Kitano, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.23123 · Cited by 31
“In addition, overexpression of COX-2 is related to poor prognosis of several cancers.47,48 Other studies showed that activation of PAR-1 or PAR-2 in response to enhanced MMP-2 and MMP-9 activities is associated with metastases of cancer cells.43 MMPs, which are enzymes capable of degrading the extracellular matrix and…”
BackgroundVilén, S., Nyberg, P., Hukkanen, M., Sutinen, M., Ylipalosaari, M., Bjartell, A. S., Paju, A., Haaparanta, V., Stenman, U., Sorsa, T. A., et al. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.10.025 · Cited by 30
Self-citationTrypsin-mediated enzymatic degradation of type II collagen in the human vitreous.
van Deemter, M., Kuijer, R., Pas, H. H., van der Worp, R. J., Hooymans, J. M. M., & Los, L. I. (2013) · PubMed Central · Cited by 30
Peltonen, R., Hagström, J., Tervahartiala, T. I., Sorsa, T. A., Haglund, C. H., & Isoniemi, H. (2020) · Oncology · doi:10.1159/000510609 · Cited by 35
Self-citationTumour-Associated Trypsin Inhibitor TATI Is a Prognostic Marker in Colorectal Cancer
Koskensalo, S., Hagström, J., Louhimo, J. M., Stenman, U., & Haglund, C. (2012) · Oncology · doi:10.1159/000336080 · Cited by 28
Self-citationChen, S., Fahmi, H., Shi, Q., & Benderdour, M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2926 · Cited by 30
“collagen with different extents and mechanisms (Moilanen et al., 2003).”
Chiang, T.-E., Lin, Y., Li, Y., Wu, C.-T., Kuo, C., & Chen, Y. (2018) · Clinical Oral Investigations · doi:10.1007/s00784-018-2691-8 · Cited by 25
Identification of pancreatic juice proteins as biomarkers of pancreatic cancer
Li (2010) · Oncology Reports · doi:10.3892/or_00000812 · Cited by 25
Andisheh‐Tadbir, A., Purshahidi, S., Ebrahimi, H., Khademi, B., Malekzadeh, M., Mardani, M., Taghva, M., & Sardari, Y. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.9.4545 · Cited by 25
“MMP-3 is produced as an inactive substrate that needs cleavage by proteolytic enzymes (like trypsin-2) for its activation (Moilanen, 2003).”
BackgroundPeptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
Ledwoń, P., Papini, A. M., Rovero, P., & Latajka, R. (2021) · Materials · doi:10.3390/ma14123217 · Cited by 27
Solakidi, S., Tiniakos, D., Petraki, K., Stathopoulos, G. P., Markaki, I., Androulakis, G., & Sekeris, C. E. (2003) · PubMed · doi:10.14670/hh-18.1181 · Cited by 23
Kocher, F., Tymoszuk, P., Amann, A., Sprung, S., Salcher, S., Daum, S., Haybaeck, J., Rinnerthaler, G., Huemer, F., Kauffmann-Guerrero, D. E., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.06.020 · Cited by 21
El‐mezayen, H. A., Metwally, F. M., & Darwish, H. (2013) · Tumor Biology · doi:10.1007/s13277-013-1366-y · Cited by 21
“TATI is thought to be a part of this net [30, 31] so it is involved in our score.”
BackgroundHuman trypsinogens in the pancreas and in cancer
Itkonen, O. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365511003615317 · Cited by 24
Nardo, C. M. D., Lenzo, J. C., Pobjoy, J., Hamilton, J. A., & Cook, A. D. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3171 · Cited by 20
“A similar pattern was observed for the aggrecanases, ADAMTS-4 (Figure 5c) and ADAMTS-5 (Figure 5d), implicated in cartilage proteoglycan breakdown [26], and for MMP-3 (stromelysin1) (Figure 5e) and MMP-13 (collagenase-3) (Figure 5f), implicated in the breakdown of extracellular matrices, including proteoglycan [26-30].”
MethodChlastáková, A., Kaščáková, B., Kotál, J., Langhansová, H., Kotsyfakis, M., Smatanová, I. K., Tirloni, L., & Chmelař, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1116324 · Cited by 19
Casey, O. M., Morris, D. G., Powell, R., Sreenan, J. M., & Fitzpatrick, R. (2005) · Theriogenology · doi:10.1016/j.theriogenology.2005.04.015 · Cited by 24
“Trypsinogen 2 is known to degrade type I collagen and can also activate latent collagenases including matrix metalloproteinases MMPs-1, -8 and -13 [43].”
BackgroundEctopic trypsin in the myocardium promotes dilated cardiomyopathy after influenza A virus infection
Pan, H., Sun, H.-M., Xue, L.-J., Pan, M., Wang, Y.-P., Kido, H., & Zhu, J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00076.2014 · Cited by 19
“Trypsin is an efficient activator of a prourokinase cascade (33).”
BackgroundEvrosimovska, B., Dimova, C., Kovacevska, I., & Panov, S. (2012) · PubMed · Cited by 18
Trypsin-2 Enhances Carcinoma Invasion by Processing Tight Junctions and Activating ProMT1-MMP
Vilén, S., Suojanen, J., Salas, F., Risteli, J., Ylipalosaari, M., Itkonen, O., Koistinen, H. K., Baumann, M., Stenman, U., Sorsa, T. A., et al. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.716467 · Cited by 18
“Our group’s earlier finding that MMP-13 is down-regulated in OSCC (10) was confirmed here by microarray analysis and Western blotting (Table 1; Supplementary Figure 1B, available online).”
BackgroundSelf-citationAndisheh‐Tadbir, A., Khademi, B., Kamali, F., Fattahi, M. J., Malekzadeh, M., & Taghva, M. (2014) · Tumor Biology · doi:10.1007/s13277-014-1753-z · Cited by 16
Collagen degradation by tumor-associated trypsins
Mirigian, L. S., Makareeva, E., Koistinen, H. K., Itkonen, O., Sorsa, T. A., Stenman, U., Salo, T. A., & Leikin, S. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.03.008 · Cited by 18
Self-citationNovel nonmatrix-metalloproteinase-mediated collagen degradation
Song, F., & Windsor, L. J. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.10.007 · Cited by 16
Patschan, O., Shariat, S. F., Chade, D. C., Karakiewicz, P. I., Ashfaq, R., Lotan, Y., Hotakainen, K., Stenman, U., & Bjartell, A. S. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0727-7 · Cited by 15
“Trypsin is also expressed by many tumors and is thought to play a role in tumor invasion [1, 3, 4].”
BackgroundSelf-citationNikolakopoulou, A. M., Georgakopoulos, A., & Robakis, N. K. R. K. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.028 · Cited by 16
Cipriani, C., Pascarella, S., Errante, F., Menicacci, B., Magnelli, L., Mocali, A., Rovero, P., & Giovannelli, L. (2018) · Cell Biology International · doi:10.1002/cbin.11018 · Cited by 19
Cederqvist, K., Janér, J., Tervahartiala, T. I., Sorsa, T. A., Haglund, C. H., Salmenkivi, K., Stenman, U., & ANDERSSON, S. M. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000238342.16081.f9 · Cited by 15
“Trypsin efficiently activates various pro-MMPs, including MMP-8 and -9, at very low concentrations by cleaving off the activation propeptide, which concomitantly results in diminished molecular weight of the target MMP (2,3).”
BackgroundSelf-citationMonitoring the treatment outcome in endometrial cancer patients by CEA and TATI
Kozakiewicz, B., Chądzyńska, M., Dmoch–Gajzlerska, E., & Stefaniak, M. (2016) · Tumor Biology · doi:10.1007/s13277-016-4784-9 · Cited by 14
Saiganesh, S., Saathvika, R., Udhaya, V., Balasubramanian, A., Mohanakrishnan, V., & Selvamurugan, N. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.091 · Cited by 15
Kong, W., Longaker, M. T., & Lorenz, H. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410804200 · Cited by 13
Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC
Wang, W.-F., Wu, L., Wu, X., Li, K., Li, T., Xu, B., & Liu, W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.12.014 · Cited by 13
Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?
Cheng, W.-H., & Wang, Y. (2025) · Cells · doi:10.3390/cells14030153 · Cited by 13
“In vitro studies have found that α -defensins increase platelet aggregation and thrombus formation [51], neutrophil elastase induces apoptosis of ECs [52], and MMP-8 breaks down collagens [53].”
Jian, M., Zhang, H., Li, X., & Wang, Z. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.129361 · Cited by 11
Hass, H. G., Jobst, J., Vogel, U. H., Scheurlen, M., & Nehls, O. (2014) · Oncology Research and Treatment · doi:10.1159/000369151 · Cited by 11
Chen, Y., Wang, B., Zhao, Z., Li, M., & Wang, F. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101949 · Cited by 10
Is Gene Expression Profiling of Head and Neck Cancers Ready for the Clinic?
Ziober, A. F., D'Alessandro, L., & Ziober, B. L. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.71 · Cited by 11
Temporary serine protease inhibition and the role of SPINK2 in human bone marrow
Barresi, V., Bella, V. D., Nigro, L. L., Privitera, A. P., Bonaccorso, P., Scuderi, C., & Condorelli, D. F. (2023) · iScience · doi:10.1016/j.isci.2023.106949 · Cited by 12
“What could be the functional meaning of the predicted tPRSS-inhibition zone in the HSCN and the tPRSSactive zone away from it? A clue is provided from studies showing that anionic trypsin can efficiently activate the collagenolytic matrix metalloproteinase (MMP)-1, -8, and -13 and their activator MMP-3.(55) Trypsin-2…”
BackgroundKasurinen, A., Laitinen, A., Kokkola, A., Stenman, U., Böckelman, C., & Haglund, C. H. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1733655 · Cited by 9
“A high TAT-2 expression enhances a tumor’s invasive capacity through increased extracellular matrix degradation via the activation of pro-urokinase and matrix metalloproteinases [14,15].”
BackgroundResultSelf-citationNew intracellular and molecular aspects in pathophysiology of colorectal cancer.
Ziapour, S. P., Ataee, R., Shadifar, M., Vaillancourt, C., Ahmadi, A. A., Jafari‐Sabet, M., & Ataee, A. (2011) · Gastroenterology and hepatology from bed to bench. · Cited by 10
Matrix metalloproteinases in pulpitis, chronic apical periodontitis and odontogenic jaw cysts
Wahlgren, J. (2003) · Helda - University of Helsinki Institutional Repository · Cited by 9
Metaloproteinases 1 e 7 e câncer colorretal
Júca, M. J., Nunes, B. L. B. B. P., de Menezes, H. L., Gomes, E. G. D. A., & Matos, D. (2008) · Revista Brasileira de Coloproctologia · doi:10.1590/s0101-98802008000300016 · Cited by 11
Trypsin causes platelet activation independently of known protease-activated receptors
Mao, Y., & Kunapuli, S. P. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0189 · Cited by 6
“Trypsin activated a number of procollagenases, including MMP-1, MMP-8, MMP-13 (31), MMP-7 (32), MMP-2 and MMP-9 (33).”
BackgroundSong, F., Bergdoll, A. S., & Windsor, L. J. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.05.002 · Cited by 6
Ridwаn, R. D. (2012) · Dental Journal (Majalah Kedokteran Gigi) · doi:10.20473/j.djmkg.v45.i4.p181-186 · Cited by 6
Pancreatic Digestive Enzyme Dispersion into Human Organs Outside the Gastrointestinal Tract
Chavan, R., & Schmid‐Schönbein, G. W. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00224 · Cited by 2
Mäntylä, P. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 5
Houessou, U., Zamani, P., Manikpurage, H. D., Li, Z., Gaudreault, N., Dahmene, M., Dagenais, F., Couture, C., Clavel, M.-A., Pibarot, P., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120791 · Cited by 1
Noninvasive biomarkers for early smoking related lung disease
Ilumets, H. (2011) · Työväentutkimus Vuosikirja · Cited by 1
Nyberg, P. (2005) · Cited by 1
Self-citationMatrix proteinases in lung injury in the preterm infant
Cederqvist, K. (2006) · Työväentutkimus Vuosikirja
Kostamo, K. (2006) · Helda - University of Helsinki Institutional Repository
Apajalahti, S. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 2
Ma, J. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 1
Matrix metalloproteinases in human wounds and epithelial cancer in the skin and oral mucosa
Impola, U. (2004) · Helda - University of Helsinki Institutional Repository
Heikkilä, P. (2005) · Työväentutkimus Vuosikirja · Cited by 1
Metadata
- Authors
- Moilanen, M., Sorsa, T., Stenman, M., Nyberg, P., Lindy, O., Vesterinen, J., Paju, A., Konttinen, Y. T., Stenman, U.-H., & Salo, T.
- Affiliations
- Oulu University Hospital (FI)
- Corresponding author
- Salo, Tuula
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-04-12
- Volume
- 42
- Issue
- 18
- Pages
- 5414-5420
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1967869198
- Cited by
- 111
- References
- 30
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 2 · 2014: 3 · 2013: 5 · 2012: 6
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- trypsinogen-2, matrix metalloproteinase activation, MMP-1, MMP-8, MMP-13, MMP-3, stromelysin-1, type I collagen degradation, tumor-associated trypsin inhibitor, extracellular matrix degradation, tumor invasion, HSC-3 cells
- MeSH terms
- Enzyme Activation, Enzyme Precursors, Extracellular Matrix, Humans, Serine Endopeptidases, Trypsin, Trypsin Inhibitor, Kazal Pancreatic, Trypsinogen, Tumor Cells, Cultured, Blotting, Western, Polymerase Chain Reaction, Collagenases, DNA Primers, Matrix Metalloproteinase 3, Matrix Metalloproteinase 1, Matrix Metalloproteinase 8, Collagen Type I, Matrix Metalloproteinase 13
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.